| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.76 | 0.004 | 0.76 | Antiadrenergic | 0.597 0.005 DBMET02738 | ||
| 0.76 | 0.004 | 0.76 | Adrenaline antagonist | 0.597 0.005 DBMET02738 | ||
| 0.547 | 0.003 | 0.547 | Electron transport complex I inhibitor | 0.521 0.003 DBMET02738 | ||
| 0.526 | 0.019 | 0.526 | Calcium channel L-type activator | 0.471 0.04 DBMET02738 | ||
| 0.492 | 0.029 | 0.492 | 5 Hydroxytryptamine release stimulant | 0.262 0.084 DBMET02738 | ||
| 0.494 | 0.035 | 0.495 | Immunosuppressant | 0.495 0.034 DBMET02738 | DBMET02738 | |
| 0.494 | 0.039 | 0.494 | Antiobesity | 0.295 0.12 DBMET02738 | ||
| 0.467 | 0.039 | 0.467 | Toll-Like receptor agonist | 0.461 0.04 DBMET02738 | ||
| 0.459 | 0.041 | 0.459 | Toll-Like receptor 7 agonist | 0.457 0.041 DBMET02738 | ||
| 0.428 | 0.019 | 0.453 | Vasodilator | 0.453 0.016 DBMET02738 | DBMET02738 | |
| 0.451 | 0.056 | 0.519 | Antibacterial | 0.519 0.035 DBMET02738 | DBMET02738 | |
| 0.353 | 0.012 | 0.353 | Alpha adrenoreceptor antagonist | 0.219 0.024 DBMET02738 | ||
| 0.415 | 0.083 | 0.478 | Cyclophilin D inhibitor | 0.478 0.057 DBMET02738 | DBMET02738 | |
| 0.324 | 0.004 | 0.324 | Adrenaline agonist | 0.215 0.005 DBMET02738 | ||
| 0.36 | 0.044 | 0.418 | Antioxidant | 0.418 0.032 DBMET02738 | DBMET02738 | |
| 0.363 | 0.049 | 0.363 | Spasmolytic | 0.258 0.088 DBMET02738 | ||
| 0.344 | 0.041 | 0.442 | Cardiotonic | 0.442 0.022 DBMET02738 | DBMET02738 | |
| 0.309 | 0.009 | 0.309 | Bronchodilator | 0.307 0.009 DBMET02738 | ||
| 0.27 | 0.013 | 0.27 | Alpha 1 adrenoreceptor antagonist | 0.172 0.025 DBMET02738 | ||
| 0.336 | 0.08 | 0.336 | Vasodilator, peripheral | 0.236 0.139 DBMET02738 | ||
| 0.285 | 0.03 | 0.286 | Peptidyltransferase inhibitor | 0.286 0.03 DBMET02738 | DBMET02738 | |
| 0.261 | 0.01 | 0.261 | 5 Hydroxytryptamine agonist | 0.122 0.027 DBMET02738 | ||
| 0.302 | 0.065 | 0.302 | Hypoxia-inducible factor 1 alpha inhibitor | 0.295 0.068 DBMET02738 | ||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | 0.231 0.047 DBMET02738 | ||
| 0.266 | 0.057 | 0.266 | DNA synthesis inhibitor | 0.237 0.076 DBMET02738 | ||
| 0.23 | 0.028 | 0.23 | Interleukin 6 antagonist | 0.225 0.029 DBMET02738 | ||
| 0.2 | 0.004 | 0.2 | Glutamate (mGluR7) agonist | 0.174 0.006 DBMET02738 | ||
| 0.345 | 0.15 | 0.345 | Caspase 9 stimulant | 0.274 0.224 DBMET02738 | ||
| 0.264 | 0.069 | 0.264 | Interleukin agonist | 0.206 0.115 DBMET02738 | ||
| 0.205 | 0.012 | 0.205 | Nav1.5 sodium channel blocker | 0.113 0.063 DBMET02738 | ||
| 0.291 | 0.099 | 0.291 | Transcription factor NF kappa B inhibitor | 0.285 0.103 DBMET02738 | ||
| 0.32 | 0.144 | 0.32 | 5 Hydroxytryptamine release inhibitor | |||
| 0.166 | 0.005 | 0.166 | Beta adrenoreceptor antagonist | 0.126 0.009 DBMET02738 | ||
| 0.163 | 0.004 | 0.163 | Beta 1 adrenoreceptor antagonist | 0.094 0.012 DBMET02738 | ||
| 0.235 | 0.078 | 0.235 | Antiamyloidogenic | 0.199 0.101 DBMET02738 | ||
| 0.188 | 0.036 | 0.188 | Topoisomerase II inhibitor | 0.147 0.051 DBMET02738 | ||
| 0.24 | 0.092 | 0.24 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.15 | 0.004 | 0.15 | Beta 2 adrenoreceptor antagonist | 0.087 0.01 DBMET02738 | ||
| 0.17 | 0.025 | 0.17 | Alpha 2c adrenoreceptor antagonist | |||
| 0.173 | 0.027 | 0.173 | Beta amyloid protein antagonist | |||
| 0.159 | 0.015 | 0.159 | Alpha adrenoreceptor agonist | |||
| 0.145 | 0.01 | 0.145 | Alpha 1 adrenoreceptor agonist | |||
| 0.155 | 0.022 | 0.155 | Hedgehog signaling inhibitor | 0.097 0.07 DBMET02738 | ||
| 0.263 | 0.131 | 0.263 | Calcium channel activator | |||
| 0.248 | 0.12 | 0.256 | Interleukin 2 agonist | 0.256 0.113 DBMET02738 | DBMET02738 | |
| 0.163 | 0.037 | 0.163 | Adenylate cyclase inhibitor | 0.139 0.053 DBMET02738 | ||
| 0.176 | 0.051 | 0.176 | Insulin secretagoues | 0.117 0.115 DBMET02738 | ||
| 0.216 | 0.099 | 0.216 | Hypoglycemic | 0.199 0.113 DBMET02738 | ||
| 0.153 | 0.037 | 0.153 | Alpha 2b adrenoreceptor antagonist | |||
| 0.139 | 0.025 | 0.139 | Alpha 1a adrenoreceptor antagonist | 0.082 0.044 DBMET02738 | ||
| 0.248 | 0.136 | 0.294 | Vasodilator, coronary | 0.294 0.092 DBMET02738 | DBMET02738 | |
| 0.105 | 0.004 | 0.105 | Beta adrenoreceptor agonist | 0.067 0.006 DBMET02738 | ||
| 0.104 | 0.01 | 0.104 | Dopamine D2 agonist | 0.052 0.025 DBMET02738 | ||
| 0.106 | 0.015 | 0.106 | Secretase beta inhibitor | 0.066 0.058 DBMET02738 | ||
| 0.154 | 0.065 | 0.162 | Protein kinase stimulant | 0.162 0.06 DBMET02738 | DBMET02738 | |
| 0.111 | 0.023 | 0.111 | Dopamine agonist | 0.079 0.038 DBMET02738 | ||
| 0.123 | 0.036 | 0.123 | Alpha 2 adrenoreceptor antagonist | |||
| 0.097 | 0.01 | 0.097 | 5 Hydroxytryptamine 2 agonist | |||
| 0.158 | 0.072 | 0.158 | Melanin inhibitor | 0.147 0.086 DBMET02738 | ||
| 0.137 | 0.052 | 0.146 | Cholesterol synthesis inhibitor | 0.146 0.046 DBMET02738 | DBMET02738 | |
| 0.116 | 0.034 | 0.138 | Lanosterol 14 alpha demethylase inhibitor | 0.138 0.017 DBMET02738 | DBMET02738 | |
| 0.083 | 0.008 | 0.083 | Beta 2 adrenoreceptor agonist | 0.071 0.017 DBMET02738 | ||
| 0.145 | 0.071 | 0.145 | Adenylate cyclase stimulant | 0.138 0.086 DBMET02738 | ||
| 0.103 | 0.031 | 0.103 | 5 Hydroxytryptamine 1A antagonist | 0.058 0.055 DBMET02738 | ||
| 0.148 | 0.076 | 0.148 | Acetylcholine M1 receptor antagonist | |||
| 0.114 | 0.045 | 0.114 | Anabolic | 0.108 0.053 DBMET02738 | ||
| 0.072 | 0.003 | 0.072 | Beta 3 adrenoreceptor agonist | 0.014 0.006 DBMET02738 | ||
| 0.088 | 0.022 | 0.088 | DNA gyrase inhibitor | |||
| 0.069 | 0.004 | 0.069 | DNA topoisomerase IV inhibitor | 0.047 0.006 DBMET02738 | ||
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | |||
| 0.177 | 0.114 | 0.177 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.098 | 0.038 | 0.098 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.117 | 0.057 | 0.117 | Mucolytic | 0.093 0.089 DBMET02738 | ||
| 0.169 | 0.111 | 0.169 | HERG channel blocker | |||
| 0.083 | 0.025 | 0.083 | 5 Hydroxytryptamine 2A agonist | |||
| 0.078 | 0.02 | 0.078 | 5 Hydroxytryptamine 1A agonist | 0.047 0.031 DBMET02738 | ||
| 0.174 | 0.124 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.179 | 0.135 | 0.179 | RNA-directed DNA polymerase inhibitor | |||
| 0.164 | 0.123 | 0.427 | Hypolipemic | 0.427 0.02 DBMET02738 | DBMET02738 | |
| 0.085 | 0.045 | 0.085 | Alpha 2a adrenoreceptor antagonist | |||
| 0.084 | 0.043 | 0.084 | Alpha 1b adrenoreceptor antagonist | |||
| 0.064 | 0.023 | 0.064 | Pregnane X receptor antagonist | |||
| 0.084 | 0.046 | 0.084 | Interferon agonist | |||
| 0.077 | 0.04 | 0.077 | Dopamine D2 antagonist | |||
| 0.109 | 0.073 | 0.109 | Photosensitizer | |||
| 0.116 | 0.082 | 0.116 | Alpha-N-acetylglucosaminidase inhibitor | 0.104 0.096 DBMET02738 | ||
| 0.125 | 0.092 | 0.125 | Cell wall synthesis inhibitor | |||
| 0.066 | 0.035 | 0.066 | Acetylcholine M5 receptor antagonist | |||
| 0.109 | 0.079 | 0.109 | Acetylcholine muscarinic antagonist | |||
| 0.117 | 0.087 | 0.117 | Sodium channel (voltage-gated) blocker | |||
| 0.068 | 0.04 | 0.109 | 5 Hydroxytryptamine uptake inhibitor | 0.109 0.023 DBMET02738 | DBMET02738 | |
| 0.073 | 0.047 | 0.073 | Phospholipase D inhibitor | |||
| 0.154 | 0.128 | 0.154 | Insulin sensitizer | |||
| 0.075 | 0.05 | 0.075 | Dopamine antagonist | |||
| 0.045 | 0.02 | 0.045 | Alpha 1d adrenoreceptor agonist | |||
| 0.066 | 0.041 | 0.066 | Interferon inducer | |||
| 0.063 | 0.039 | 0.063 | Alpha 1d adrenoreceptor antagonist | |||
| 0.063 | 0.039 | 0.063 | Alpha 2 adrenoreceptor agonist | |||
| 0.07 | 0.048 | 0.07 | HIV-1 integrase inhibitor | |||
| 0.051 | 0.031 | 0.082 | Sodium/calcium exchanger inhibitor | 0.082 0.008 DBMET02738 | DBMET02738 | |
| 0.113 | 0.093 | 0.113 | Sodium channel blocker | |||
| 0.054 | 0.036 | 0.054 | Leukotriene B4 antagonist | 0.053 0.039 DBMET02738 | ||
| 0.083 | 0.066 | 0.083 | Interleukin 5 antagonist | |||
| 0.118 | 0.102 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.052 | 0.036 | 0.052 | 5 Hydroxytryptamine 1 agonist | |||
| 0.046 | 0.031 | 0.046 | 5 Hydroxytryptamine 2C agonist | |||
| 0.046 | 0.031 | 0.046 | Adenylate cyclase 1 inhibitor | |||
| 0.044 | 0.03 | 0.044 | Stearoyl-CoA desaturase inhibitor | 0.043 0.032 DBMET02738 | ||
| 0.05 | 0.036 | 0.05 | Thromboxane A2 antagonist | |||
| 0.031 | 0.018 | 0.031 | Thiazolidinedione | |||
| 0.042 | 0.03 | 0.042 | DNA gyrase subunit A inhibitor | |||
| 0.064 | 0.053 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.033 | 0.023 | 0.033 | Melatonin 1 agonist | |||
| 0.036 | 0.026 | 0.042 | Antibiotic Aminoglycoside-like | 0.042 0.019 DBMET02738 | DBMET02738 | |
| 0.115 | 0.105 | 0.115 | Peroxidase inhibitor | |||
| 0.028 | 0.019 | 0.066 | Leukotriene B4 receptor 1 antagonist | 0.066 0.005 DBMET02738 | DBMET02738 | |
| 0.068 | 0.059 | 0.068 | Phosphodiesterase VIII inhibitor | |||
| 0.095 | 0.086 | 0.095 | DOPA decarboxylase inhibitor | |||
| 0.051 | 0.042 | 0.051 | Alpha-mannosidase inhibitor | 0.049 0.047 DBMET02738 | ||
| 0.128 | 0.121 | 0.18 | Nitric oxide antagonist | 0.18 0.077 DBMET02738 | DBMET02738 | |
| 0.022 | 0.016 | 0.068 | Leukotriene B4 receptor 2 antagonist | 0.068 0.004 DBMET02738 | DBMET02738 | |
| 0.084 | 0.078 | 0.084 | Glutamate release inhibitor | |||
| 0.031 | 0.026 | 0.031 | Melatonin 2 agonist | |||
| 0.135 | 0.13 | 0.152 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET02738 | DBMET02738 | |
| 0.135 | 0.13 | 0.135 | Psychostimulant | |||
| 0.047 | 0.043 | 0.047 | Alpha 1b adrenoreceptor agonist | |||
| 0.024 | 0.021 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 DBMET02738 | DBMET02738 | |
| 0.021 | 0.017 | 0.021 | Alpha 1a adrenoreceptor agonist | |||
| 0.053 | 0.05 | 0.053 | Acetylcholine M3 receptor antagonist | |||
| 0.037 | 0.034 | 0.037 | Secretase gamma inhibitor | |||
| 0.047 | 0.045 | 0.047 | Thromboxane antagonist | |||
| 0.087 | 0.086 | 0.087 | Ferrochelatase inhibitor | |||
| 0.024 | 0.024 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET02738 | DBMET02738 | |
| 0.046 | 0.054 | 0.069 | Dopamine uptake inhibitor | 0.069 0.031 DBMET02738 | DBMET02738 | |
| 0.059 | 0.072 | 0.07 | Na+ K+ transporting ATPase inhibitor | 0.07 0.06 DBMET02738 | DBMET02738 | |
| 0.044 | 0.073 | 0.081 | Adrenaline uptake inhibitor | 0.081 0.026 DBMET02738 | DBMET02738 | |
| 0.178 | 0.208 | 0.203 | Caspase 3 stimulant | 0.203 0.164 DBMET02738 | DBMET02738 | |
| 0.034 | 0.067 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET02738 | DBMET02738 | |
| 0.038 | 0.076 | 0.081 | NMDA 2B receptor antagonist | 0.081 0.021 DBMET02738 | DBMET02738 | |
| 0.021 | 0.065 | 0.054 | HMG CoA reductase inhibitor | 0.054 0.005 DBMET02738 | DBMET02738 | |
| 0.098 | 0.168 | 0.126 | NOS3 expression enhancer | 0.126 0.105 DBMET02738 | DBMET02738 | |
| 0.035 | 0.11 | 0.089 | Antineoplastic antibiotic | 0.089 0.052 DBMET02738 | DBMET02738 | |
| 0.024 | 0.107 | 0.044 | Dopamine transporter inhibitor | 0.044 0.039 DBMET02738 | DBMET02738 | |
| 0.083 | 0.233 | 0.152 | Hepatoprotectant | 0.152 0.107 DBMET02738 | DBMET02738 | |
| 0.115 | 0.315 | 0.214 | Immunomodulator | 0.214 0.148 DBMET02738 | DBMET02738 | |
| 0.035 | 0.249 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.053 DBMET02738 | DBMET02738 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |